Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
about
Recent topics in chemical and clinical research on glycated albuminUpdate on pre-diabetes: Focus on diagnostic criteria and cardiovascular riskMetrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1cGlycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetesOxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.Salivary protein glycosylation as a noninvasive biomarker for assessment of glycemia.Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetesA Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research Literature.Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study.Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes.GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.Effects of a new combination of nutraceuticals on postmenopausal symptoms and metabolic profile: a crossover, randomized, double-blind trial.Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial.Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.Methanolic Extract of Dill Leaves Inhibits AGEs Formation and Shows Potential Hepatoprotective Effects in CCl4 Induced Liver Toxicity in Rat.Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy.Oxidative stress, protein glycation and nutrition--interactions relevant to health and disease throughout the lifecycle.Rising HbA1c in the presence of optimal glycaemic control as assessed by self-monitoring - iron deficiency anaemia.Prediabetes and associated disorders.The Early Diabetes Intervention Program--is early actually late?Abundance matters: role of albumin in diabetes, a proteomics perspective.Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.Glycated albumin: from biochemistry and laboratory medicine to clinical practice.Glycated albumin: a potential biomarker in diabetes.DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease.High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.Race, APOL1 Risk, and eGFR Decline in the General Population.Novel biomarkers for prediabetes, diabetes, and associated complications.Aqueous Extract of Anethum Graveolens L. has Potential Antioxidant and Antiglycation Effects.Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study.Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
P2860
Q26865088-2FC01684-3E17-4C31-A837-6D1BF1DF1E0AQ28073749-BA0F78ED-8D3C-4D9D-9786-EE2F6FE9EDB1Q33727475-BC57FA32-5720-4FB7-AD06-F37ACDE21D89Q34421046-BA4C0AFB-54B1-461B-9D2B-DA9BD68A33B5Q34425731-DF6DE550-48BD-4479-8737-4A3ECEA53BDFQ34433155-B504D5C5-39A6-4763-AD3F-A8F7D420D33AQ34486820-0229DC82-2030-4160-A686-56EB5776BC5FQ35101926-6426EFC7-EDB3-4666-B5B5-1B3AAF5828E8Q35627229-1003A712-5BB8-4A82-9526-0563AA872328Q35684097-B11F667D-F8C4-4F9C-AA9D-426AE13D0C28Q35830450-DEDB06D8-BFD1-43B9-9727-7A3A6F9253E2Q36159157-2E7BE16D-B07B-46F2-9F5E-9EBB7FF18DDAQ36176050-D4EFA3A8-B4CE-47E6-9F60-79BC78B0C3CFQ36181805-4530FBCE-257E-426A-8F1E-761755442A6CQ36726169-1A92DE7E-6A8F-4651-9984-140D92C19F0BQ36926403-950DF2C5-C428-454E-9EA6-973CB37F568CQ37007055-0CC6A5A4-4503-4AE8-99BB-3A2A980819FDQ37230203-B8985F9E-275F-4E16-9191-2E31560DE3DCQ37344277-13EFAABF-D0C5-4781-940E-F9DA23F6B187Q37394223-2594049D-892A-4FF2-9073-468603DCAE6EQ37454656-A2E54044-1F27-4555-8DC7-12EC7B42D854Q37611305-F283BEE1-6A51-432A-A271-3ABE8D5272BDQ37733547-50992702-EA45-4C86-9013-12F8C85D0E61Q38216061-33C6549D-F7A5-4C24-B991-66F21D299B82Q38257928-28F87C67-5E89-4869-84C0-8BACF712D0CCQ38257985-7C09624B-E7AB-438C-BBA8-B62A0404E974Q38268577-7DC2CA80-4E86-4D11-9F1D-BD9D9F4DF19FQ38660810-7717F5E9-F2CF-4386-9749-5B571537AFDAQ38800986-0E03F530-25DD-4B27-90DF-9E1C33593CA1Q38837915-413A5AD3-31AE-47B1-95EE-89CC0999197BQ38953440-D1170498-1058-4330-A257-AEF8B288F61AQ39430493-6A426A3D-B33E-4D05-85D3-3ABAD2DFF3CEQ39494977-7EB261EA-BF99-4E40-915C-8725E812CA10Q40370710-FA8A417C-51CA-4D2C-80B0-9272ABE43B11Q40860089-595C2871-A1E6-4EAF-9D62-4CFF42411F52Q41475816-3E5F8B18-9AD8-4134-8EF7-A21A22ABCA1BQ41808635-1241BA0A-7A81-4179-80D8-501DD7DBDE62Q42096270-F4FF838E-E5A9-4083-A7F3-83F713DC82F6Q42373709-1E56AAD7-6050-450B-963F-7AC0ED7B271CQ42374501-983EF822-4C58-4C19-8358-0F4055170BC6
P2860
Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@ast
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@en
Fructosamine and glycated albu ...... osclerosis Risk in Communities
@nl
type
label
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@ast
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@en
Fructosamine and glycated albu ...... osclerosis Risk in Communities
@nl
prefLabel
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@ast
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@en
Fructosamine and glycated albu ...... osclerosis Risk in Communities
@nl
P2093
P2860
P1476
Fructosamine and glycated albu ...... k in Communities (ARIC) study.
@en
P2093
A Richey Sharrett
Andreea M Rawlings
Michael Steffes
Morgan Grams
Ronald Klein
P2860
P304
P356
10.1016/S2213-8587(13)70199-2
P577
2014-01-15T00:00:00Z